All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Haleon demerger shows spin-offs don’t protect from terrible markets

The American pharmaceutical company Pfizer has decided to sell its share in the consumer health care company Haleon, which is co-owned with the British GSK, in connection with a stock exchange listing planned for 18 July. Haleon owns brands such as the pa

GSK’s consumer health business trades down on London debut

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree